The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 16, 2021
Filed:
Dec. 11, 2015
Applicant:
B.r.a.h.m.s Gmbh, Hennigsdorf, DE;
Inventors:
Assignee:
B.R.A.H.M.S GMBH, Hennigsdorf, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 49/16 (2006.01); A61B 5/00 (2006.01); G01N 33/53 (2006.01); G01N 33/74 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01); G01N 33/557 (2006.01); A61K 38/16 (2006.01); C07K 16/18 (2006.01); A61K 38/23 (2006.01); G01N 33/48 (2006.01);
U.S. Cl.
CPC ...
G01N 33/74 (2013.01); G01N 33/50 (2013.01); G01N 33/53 (2013.01); G01N 33/6896 (2013.01); A61K 38/16 (2013.01); A61K 38/23 (2013.01); C07K 16/18 (2013.01); G01N 33/48 (2013.01); G01N 33/557 (2013.01); G01N 2333/00 (2013.01); G01N 2333/435 (2013.01); G01N 2333/585 (2013.01); G01N 2800/28 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/56 (2013.01);
Abstract
CSF diagnostic in vitro method for the diagnosis of dementias and neuroinflammatory diseases, in which a determination of the procalcitonin immunoreactivity (PCT immunoreactivity) is carried out in a sample of cerebrospinal fluid (CSF) of a patient who is suffering from a dementia or neuroinflammatory disease or is suspected of suffering from such a disease. Conclusions about the presence, the course, the severity or the success of a treatment of the dementia or neuroinflammatory disease are drawn from a measured PCT immunoreactivity which is above a threshold value typical for healthy individuals.